|
Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment using a real mD. We aren't mDs. Always confer with your physician on Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz Clinical research trials and Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz healthcare trials happen in a lot of of localities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The aim of the studies / undertakings is to answer particular human medical questions. Clinical trials are a popular manner for doctors, government agencies, and private sector corporations to discover remedies for all kinds of circumstances, such as Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz. Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz Clinical Trials and other clinical trials allow volunteers to get healthcare treatment alternatives before they are available to the general public. Most times the participants receive treatment for without cost, and occasionally they are paid for their time. Sometimes there is a cost for a Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz clinical trial. Human subjects often receive the most effective healthcare possible for their Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz condition. Risks are a reality, nonetheless, and may include more or frequent dr. calls, healthcare hazards (perhaps life-threatening), and/or the treatment being ineffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "P" Clinical Trials Conditions > Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz  Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz
Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz
For Condition: Tuberculosis,HIV Infections
Status: No longer recruiting
Sponsor(s): Centers for Disease Control and Prevention , Department of Veterans Affairs
Synopsis: The aim of this trial is to study the efavirenz-rifabutin interaction. Thus, this trial will enroll patients with HIV and tuberculosis co-infections who are receiving a rifabutin-based regimen and who plan to begin an antiretroviral regimen containing efavirenz dosed at 600 mg daily. Enrollment in TB Trials Consortium Study 23 is not a requirement for participation in this study. Primary Objective: To compare the pharmacokinetics of rifabutin at 600 mg twice a week in combination with efavirenz 600 mg daily to the pharmacokinetics of rifabutin 300 mg twice a week without efavirenz.
Details:
Eligibility:
Study Type: Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Pharmacokinetics Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Patients with HIV and tuberculosis co-infections who are receiving a rifabutin-based regimen and who plan to begin an antiretroviral regimen containing efavirenz dosed at 600 mg daily.
Total Enrollment: 20
Location and Contact Information:
Columbia University/Presbyterian Medical Center
New York City, New York, 10032
United States
Seattle King County Health Department
Seattle, Washington, 98104
United States
Thomas Street Clinic
Houston, Texas, 77009
United States
Harlem Hospital Center
New York City, New York, 10037
United States
New York University School of Medicine
New York City, New York, 10016
United States
Nashville VA Medical Center
Nashville, Tennessee, 37212-2637
United States
Washington, D.C. VAMC
Washington D.C., District of Columbia, 20422
United States
University of British Columbia
Vancouver, British Columbia, Canada V5Z 4R4
Canada
Duke University Medical Center
Durham, North Carolina, 34222
United States
Chicago VA Medical Center (Lakeside)
Chicago, Illinois, 60611
United States
University of California, San Francisco
San Francisco, California, 94110
United States
University of Manitoba
Winnipeg, Manitoba, CANADA R3A 1R8
Canada
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21287-0003
United States
LA County/USC Medical Center
Los Angeles, California, 90033
United States
New Jersey Medical School
Newark, New Jersey, 07107-3001
United States
Carolinas Medical Center
Charlotte, North Carolina, 28203
United States
Hines VA Medical Center
Hines, Illinois, 60141
United States
Denver Department of Public Health and Hospitals
Denver, Colorado, 80204
United States
Boston Medical Center
Boston, Massachusetts, 02118
United States
Audi L. Murphy VA Hospital
San Antonio, Texas, 78284
United States
Montreal Chest Institute McGill University
Montreal, Quebec, H2X 2P4Pq Canada
Canada
University of North Texas Health Science Center
Ft. Worth, Texas, 76107-2699
United States
Central Arkansas Veterans Health System
Little Rock, Arkansas, 72205
United States
Additional Information:
Study ID Numbers: 2588; 23C
Study Start Date: November 1999
Record last reviewed: February 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00023413
Other Hiv Infections Studies:
1. Tuberculosis Prophylaxis in the Homeless--A Controlled Trial
2. Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen
3. TB Contact Investigation: Behavioral Intervention
4. A Registry of Tuberculosis Cases in the CPCRA
5. Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection
Related Studies:
Other HIV Infections Clinical Trials
Other Arkansas Clinical Trials
Other Little Rock Clinical Trials
Pharmacokinetics of Intermittent Rifabutin and Isoniazid with Daily Efavirenz
|
|
|
|
|
|
|
|
